Equity Details
Price & Market Data
Price: $1.69
Daily Change: -$0.04 / 2.37%
Daily Range: $1.61 - $2.25
Market Cap: $66,178,244
Daily Volume: 76,460
Performance Metrics
1 Week: -10.11%
1 Month: -20.66%
3 Months: -36.23%
6 Months: -32.94%
1 Year: -27.16%
YTD: -42.71%
About Sera Prognostics, Inc. (SERA)
Explore the latest financial data for Sera Prognostics, Inc. (SERA). Price: 1.69, daily change: -$0.04 / 2.37%. Market cap: 66,178,244. Performance over 1-month, 6-month, and 1-year.
Company Details
Employees: 72
Sector: Health services
Industry: Medical/Nursing services
Country: United States
Details
Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests, and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation. It is also involved in the development of a pipeline of novel blood-based biomarker tests and predictive analytic products and services for pregnancy related conditions, such as time-to-birth, predictive analytics product, pregnancy risk prediction panel, preeclampsia, and fetal growth restriction. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.